DE LUCA, ANTONIO
 Distribuzione geografica
Continente #
EU - Europa 3.653
NA - Nord America 2.834
AS - Asia 1.361
SA - Sud America 127
AF - Africa 44
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 8.028
Nazione #
US - Stati Uniti d'America 2.800
IT - Italia 2.227
SG - Singapore 561
CN - Cina 371
HK - Hong Kong 254
SE - Svezia 239
DE - Germania 222
NL - Olanda 158
FR - Francia 131
RU - Federazione Russa 114
BR - Brasile 111
PL - Polonia 109
FI - Finlandia 82
UA - Ucraina 60
IE - Irlanda 55
GB - Regno Unito 52
BG - Bulgaria 49
CH - Svizzera 28
TR - Turchia 26
AT - Austria 24
IN - India 23
CA - Canada 19
JP - Giappone 18
KR - Corea 18
BE - Belgio 17
RO - Romania 17
VN - Vietnam 17
IR - Iran 16
GR - Grecia 14
SN - Senegal 11
ES - Italia 10
EG - Egitto 9
LK - Sri Lanka 7
SI - Slovenia 7
TH - Thailandia 7
AR - Argentina 6
CZ - Repubblica Ceca 6
HU - Ungheria 6
MX - Messico 6
ZA - Sudafrica 6
DK - Danimarca 5
BD - Bangladesh 4
DZ - Algeria 4
EU - Europa 4
IL - Israele 4
IQ - Iraq 4
LU - Lussemburgo 4
MA - Marocco 4
PE - Perù 4
SC - Seychelles 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
BH - Bahrain 3
BY - Bielorussia 3
CR - Costa Rica 3
ID - Indonesia 3
KG - Kirghizistan 3
PA - Panama 3
PK - Pakistan 3
QA - Qatar 3
TN - Tunisia 3
CL - Cile 2
EC - Ecuador 2
EE - Estonia 2
LT - Lituania 2
LV - Lettonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
RS - Serbia 2
AM - Armenia 1
AZ - Azerbaigian 1
CI - Costa d'Avorio 1
CO - Colombia 1
CY - Cipro 1
GE - Georgia 1
GT - Guatemala 1
IM - Isola di Man 1
JM - Giamaica 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 8.028
Città #
Chandler 387
Fairfield 337
Singapore 334
Hong Kong 247
Ashburn 226
Milan 197
Rome 161
Trieste 156
Houston 144
Seattle 142
Woodbridge 142
Wilmington 135
Ann Arbor 116
Cambridge 113
Boardman 96
Warsaw 87
Beijing 77
Princeton 72
Columbus 53
Santa Clara 52
Dublin 51
Naples 50
Bologna 49
Florence 49
Sofia 49
Hefei 45
Jacksonville 44
Helsinki 42
Frankfurt am Main 35
Moscow 34
Palermo 33
Munich 31
Los Angeles 30
Padova 30
Turin 30
San Diego 23
Düsseldorf 22
Genoa 22
Grafing 21
Izmir 19
Venezia 19
Lappeenranta 18
Redmond 18
Amsterdam 17
Brussels 17
Seoul 17
Dearborn 16
Mykolayiv 16
Foggia 15
Guangzhou 15
Vienna 15
Bern 14
Tehran 14
Vicenza 14
Napoli 13
Redwood City 13
Toronto 13
Udine 13
Athens 12
Bari 12
Catania 12
Dong Ket 12
São Paulo 12
The Dalles 12
Treviso 12
Turku 12
Venice 12
Wroclaw 12
Dakar 11
Nuremberg 11
Pune 11
Bergamo 10
Bremen 10
Jinan 10
Roubaix 10
Washington 10
Pescara 9
Shanghai 9
Council Bluffs 8
Dallas 8
Dongguan 8
London 8
New York 8
Phoenix 8
Torino 8
Catanzaro 7
Cinisello Balsamo 7
Colombo 7
Falls Church 7
Ferrara 7
Genova 7
Lucca 7
Nanjing 7
Parma 7
Portsmouth 7
Reggio Emilia 7
Rio de Janeiro 7
San Vito al Tagliamento 7
Torre Santa Susanna 7
Verona 7
Totale 4.642
Nome #
Inquadramento e gestione della pericardite costrittiva: revisione critica 1.628
Inquadramento e gestione delle cardiomiopatie: il protocollo della Cardiologia di Trieste 304
Factor-V HR2 haplotype and thromboembolic disease 293
Facciamo il punto: miocardio non compatto 279
Malfunction of cardiac devices after radiotherapy without direct exposure to ionizing radiation: Mechanisms and experimental data 242
Vanished myxoma due to systemic embolization 215
Treatment of Functional Mitral Regurgitation in Heart Failure 215
Arrhythmic Risk Stratification in Patients With Idiopathic Dilated Cardiomyopathy 202
Predicting device failure after percutaneous repair of functional mitral regurgitation in advanced heart failure: Implications for patient selection 197
Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy 178
Left ventricular noncompaction, morphological, and clinical features for an integrated diagnosis 168
Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessment. 158
Radiotherapy and risk of implantable cardioverter-defibrillator malfunctions: experimental data from direct exposure at increasing doses 154
Percutaneous mitral valve repair: The last chance for symptoms improvement in advanced refractory chronic heart failure? 150
Usefulness of Addition of Magnetic Resonance Imaging to Echocardiographic Imaging to Predict Left Ventricular Reverse Remodeling in Patients With Nonischemic Cardiomyopathyhttps://arts.units.it/submit?resume=115962# 148
Cardiac hamartoma 140
Arrhythmic risk stratification by cardiac magnetic resonance tissue characterization: disclosing the arrhythmic substrate within the heart muscle 139
Role of right ventricular involvement in acute myocarditis, assessed by cardiac magnetic resonance 135
Echocardiographic Biventricular Coupling Index to Predict Precapillary Pulmonary Hypertension 134
Increased myocardial extracellular volume is associated with myocardial iron overload and heart failure in thalassemia major 132
PATHOLOGY. 127
Prevalence and prognostic significance of ischemic late gadolinium enhancement pattern in non-ischemic dilated cardiomyopathy 126
Prognostic Value of Magnetic Resonance Phenotype in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy 124
A 20-year experience in cardiac tumors: a single center surgical experience and a review of literature 123
Prognostic Value of Global Longitudinal Strain-Based Left Ventricular Contractile Reserve in Candidates for Percutaneous Correction of Functional Mitral Regurgitation: Implications for Patient Selection 123
Sacubitril/Valsartan Induces Global Cardiac Reverse Remodeling in Long-Lasting Heart Failure with Reduced Ejection Fraction: Standard and Advanced Echocardiographic Evidences 112
Global Right Heart Assessment with Speckle-Tracking Imaging Improves the Risk Prediction of a Validated Scoring System in Pulmonary Arterial Hypertension 112
Antiarrhythmic therapy and risk of cumulative ventricular arrhythmias in arrhythmogenic right ventricle cardiomyopathy 106
Cardiac Magnetic Resonance Feature-Tracking Identifies Preclinical Abnormalities in Hypertrophic Cardiomyopathy Sarcomere Gene Mutation Carriers 105
A case of primary cardiac sarcoma with an acute presentation: The role of multimodality imaging 95
CORRELATION BETWEEN TISSUE ABNORMALITIES AND MYOCARDIAL DEFORMATION INDICES IN ARRHYTHMOGENIC CARDIOMYOPATHY: A MULTIMODALITY IMAGING STUDY. 94
Inferior Vena Cava Edge Tracking Echocardiography: A Promising Tool with Applications in Multiple Clinical Settings 92
Focus on arrhythmogenic right ventricular cardiomyopathy 91
Prevalence and predictors of persistent sinus rhythm after elective electrical cardioversion for atrial fibrillation 90
The alcohol-induced cardiomyopathy: A cardiovascular magnetic resonance characterization 90
Modifications of medical treatment and outcome after percutaneous correction of secondary mitral regurgitation 86
Impact on clinical outcomes of right ventricular response to percutaneous correction of secondary mitral regurgitation 86
Clinical impact of myocardial fibrosis in severe aortic stenosis 85
The right ventricular involvement in dilated cardiomyopathy: prevalence and prognostic implications of the often-neglected child 80
Radiologia cardiovascolare. 70 anni di immagini dall’“Archivio Camerini” ai giorni nostri 74
The Arrhythmic Phenotype in Cardiomyopathy 73
Longitudinal Arrhythmic Risk Assessment Based on Ejection Fraction in Patients with Recent-Onset Nonischemic Dilated Cardiomyopathy 67
Genetic analyses of the electrocardiographic QT interval and its components identify additional loci and pathways 63
Abnormal conduction-induced cardiomyopathy: a poorly explored entity 63
Dark papillary muscles sign: a novel prognostic marker for cardiac magnetic resonance 61
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies 61
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator 59
Myocardial iron overload by cardiovascular magnetic resonance native segmental T1 mapping: a sensitive approach that correlates with cardiac complications 50
Hepatic T1-time, cardiac structure and function and cardiovascular outcomes in patients with dilated cardiomyopathy 49
Bioprosthetic pulmonary valve dysfunction in a primary cardiac sarcoma survivor: Clinical considerations and treatment options 47
Atrial electro-functional predictors of incident atrial fibrillation in cardiac amyloidosis 46
Conoscere e Curare il Cuore 2024 - Le cardiomiopatie da disturbo di conduzione 44
Genetic architecture of spatial electrical biomarkers for cardiac arrhythmia and relationship with cardiovascular disease 43
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality 41
Role of arrhythmic phenotype in prognostic stratification and management of dilated cardiomyopathy 40
In-hospital evolution of secondary mitral regurgitation in acutely decompensated heart failure 38
The role of echocardiography in sports cardiology: An expert opinion statement of the Italian Society of Sports Cardiology (SIC sport) 38
Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe 38
Dynamic evolution of tricuspid regurgitation during hospitalization in patients with acute decompensated heart failure 33
The additive prognostic value of end-systolic pressure-volume relation by stress CMR in patients with known or suspected coronary artery disease 29
Hot Phases Cardiomyopathy: Pathophysiology, Diagnostic Challenges, and Emerging Therapies 29
Critical analysis of the 2023 ESC guidelines on cardiomyopathy management 20
Arrhythmic risk stratification in patients with left ventricular ring-like scar 15
Absence of long-term incremental prognostic value of inducible wall motion abnormalities on dipyridamole stress CMR in patients with suspected or known coronary artery disease 14
Fenotypic expressions and clinical manifestations of arrhythmogenic cardiomyopathy 10
Integrated role of cardiac magnetic resonance and genetics in predicting left ventricular reverse remodelling in dilated and non-dilated cardiomyopathy 6
Unveiling the limitations of non-metabolic thresholds in assessing maximal effort: The role of cardiopulmonary exercise testing 3
Late Gadolinium Enhancement Dispersion for predicting malignant arrhythmic events in patient with non-ischemic Dilated Cardiomyopathy 2
Totale 8.314
Categoria #
all - tutte 25.533
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.533


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202060 0 0 0 0 0 0 0 0 0 0 0 60
2020/2021777 43 85 89 127 51 31 75 40 38 79 48 71
2021/2022820 65 63 49 72 62 78 31 32 86 79 66 137
2022/20231.464 101 155 165 195 94 175 38 136 140 63 114 88
2023/20241.363 89 73 76 105 109 139 212 151 36 95 154 124
2024/20252.488 91 134 264 215 218 164 159 172 310 351 237 173
Totale 8.314